Tuesday, 18 Jun 2019

You are here

RheumNow ACR Week in Review: ACR Wrap-Up (10.26.18)

This past week in Chicago gave us a plethora of new and eye-opening research, people, KOLs, exhibits, sessions, guidelines, posters and a never-ending supply of coffee served in small paper cups.  ACR 2018 highlights for me included:

ACR8.RheumNow.com – featuring over 1000 new content pieces – tweets, videos, panel discussions, convention and Chicago pics, quotes from notable teachers. Find your info, your way – navigate by header boxes (for RA, PsA, AS, Gout, OP), click on reports by Day (D1, D2, etc), click on category buttons (RA, PsA, gout, etc) or on the video, news buttons or use the seach field.  My favorites about this site include the RheumNow Roundtable panel discussions (especially the PsA, Gout and Spondylitis Panels), Videos by Dr. Dao on Great Debate, Dr. Tate on Exhibitor smack-down, Dr. Sam Whittle on SCOT trial and Dr. David Liew on irAE with Checkpoint inhibitors.  Lastly checkout the talking head audio commentaries found on the RA, PsA, AS, Gout and OP pages of the websites – 30 second morsels of expert commentary related to an abstract our Topic Editors found interesting. Click HERE to go to the ACR18 website

 

Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

EULAR 2019- Day 4 Report

Saturday June 15th was the last half-day at EULAR 2019 but was highlighted by the “late-breaking” (LB) presentations that were presented from the podium and by poster.

Below are the top “LB” presentations from EULAR this year:

Understanding Non-arthritic Rheumatic iRAEs

A better understanding of rheumatic immune-related adverse event phenotypes beyond inflammatory arthritis has been furthered by work from three abstracts presented at EULAR 2019 in Madrid.

Ultrasound Reveals Which Anti-CCP Positive Patients Progress to Arthritis 

Power Doppler signal on baseline ultrasound exam may well help stratify anti-CCP positive patients with musculoskeletal symptoms but no clinical synovitis, according to data from the Leeds Institute of Rheumatic and Musculoskeletal Medicine presented at EULAR 2019.

EULAR 2019 – Day 3 Report

The third day of EULAR 2019 started with novel biologics, the efficacy of secukinumab in axial psoriatic arthritis, neurologic events with TNF inhibitors from the DANBIO database (OP0261), and neuropathy in SLE (OP0252), but above all this was a big poster day. Here are selected highlights from day 3 EULAR in Madrid.

RheumNow Podcast – EULAR 2019 Streamin' - (6.14.19)

Dr. Jack Cush reports from Madrid on several novel presentations from EULAR 2019.

1. Genovese Vagal nerve stimulator in RA

2. Low dose steroids in Hand OA